Lessons From Spinal Cord Stimulator Malpractice Claims
By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine
Published January 21, 2025 | Category: Pain Medicine
Spinal cord stimulators (SCS) are implanted devices that deliver electrical pulses to the spinal cord to relieve chronic pain. The FDA has received reports of more than 80,000 injuries related to these devices, making them one of the most frequently flagged medical devices. A study in Interventional Pain Medicine reviewed malpractice cases involving SCS to identify patterns and lessons for safer practice.
This summary is based on the published abstract. Read the abstract on PubMed
What the authors did
The authors searched two legal databases (Westlaw Edge and VerdictSearch) for malpractice cases filed between 2000 and 2022 involving spinal cord stimulators. Of 1,773 cases reviewed, 45 met their criteria. They recorded the type of claim, the defendant's specialty, the outcome, payments and injuries.
What they found
- Claims were grouped as battery or generator malfunction (36%), lead complications (29%), surgical complications (20%) and other issues (16%).
- 68% of cases ended in a defense verdict, 24% in a plaintiff verdict and 9% in settlement.
- Claims involving infection were more likely to end in a defense verdict, while claims involving neurological injury were more likely to end in a plaintiff verdict.
- The four settlements averaged about $2 million.
Key lessons the authors identified
- Obtain adequate preoperative imaging, such as MRI, before implantation.
- Specifically disclose neurological risks, including paralysis, during informed consent.
- Confirm proper lead placement with front-to-back and side-view X-rays during and after the procedure.
Why this matters
Malpractice claims are only a small window into patient harm, but they highlight where outcomes are most serious and where prevention steps are clearest. Many of the practices identified here, such as careful imaging and thorough consent, are already part of good care.
Limitations
The legal databases capture only a fraction of claims, mainly those that went to trial or were reported. The study cannot tell whether care in any individual case met or fell short of the standard of care.
Safety takeaways: how to apply it
For pain physicians and procedure teams
- Review recent spine imaging before trials and implants to identify stenosis or other risks.
- Discuss serious risks, including nerve injury and paralysis, during consent, and document the discussion.
- Confirm lead position on two X-ray views, and document device checks and follow-up.
For hospitals, clinics and safety leaders
- Build imaging review, consent and lead-position documentation into neuromodulation checklists.
For patients and families
- Ask about the specific risks of the device and how problems such as battery or lead issues are handled.
Reference
- Kejriwal S, Weldon E, Carter D, Agonias K, Razzouk J, Bohen D, et al. Analysis of reasons for medical malpractice litigation due to spinal cord stimulator. Interv Pain Med. 2023 Dec;2(4):100376. doi:10.1016/j.inpm.2023.100376. PMID: 39239221. PubMed: https://pubmed.ncbi.nlm.nih.gov/39239221/
This article is educational information, not legal or medical advice.